Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

被引：2
|
作者：
Hansen, Jean M.
Ring, Karl Lassen
Baggerly, Keith A.
Wu, Sherry
Timms, Kirsten
Neff, Christopher
Hughes, Elisha
Previs, Rebecca A.
Broaddus, Russell
Coleman, Robert L.
Lu, Karen H.
Sood, Anil
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Myriad Genetics Inc, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5584
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Homologous recombination deficiency (HRD) score predicts response to platinum-based chemotherapies in Chinese high grade serous ovarian cancer patients
    Wen, Hao
    Feng, Zheng
    Yuan, Wuzhou
    Zhou, Xiaoyan
    Wu, Xiaohua
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S108 - S109
  • [32] Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
    Telli, Melinda L.
    Timms, Kirsten M.
    Reid, Julia
    Hennessy, Bryan
    Mills, Gordon B.
    Jensen, Kristin C.
    Szallasi, Zoltan
    Barry, William T.
    Winer, Eric P.
    Tung, NadineM.
    Isakoff, Steven J.
    Ryan, Paula D.
    Greene-Colozzi, April
    Gutin, Alexander
    Sangale, Zaina
    Iliev, Diana
    Neff, Chris
    Abkevich, Victor
    Jones, Joshua T.
    Lanchbury, Jerry S.
    Hartman, Anne-Renee
    Garber, Judy E.
    Ford, James M.
    Silver, Daniel P.
    Richardson, Andrea L.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3764 - 3773
  • [33] Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.
    Incorvaia, Lorena
    Brando, Chiara
    Perez, Alessandro
    Bono, Marco
    Cancelliere, Daniela
    Pivetti, Alessia
    Barraco, Nadia
    Contino, Silvia
    Raso, Chiara Annamaria
    Carreca, Anna Paola
    Gristina, Valerio
    Galvano, Antonio
    Russo, Tancredi Didier Bazan
    Castellana, Luisa
    Insalaco, Lavinia
    Fanale, Daniele
    Marchetti, Claudia
    Bazan, Viviana
    Russo, Antonio
    Carreca, Ignazio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Homologous-recombination deficiency (HRD) in gastroesophageal adenocarcinoma (GEA): Clinical and molecular features
    Acosta Eyzaguirre, D.
    Castillo, G.
    Aguilar Izquierdo, S.
    Cruellas Lapena, M.
    Herencia Ropero, A.
    Landolfi, S.
    Palma, H.
    Tian, T.
    Vivancos, A.
    Serra Elizalde, V.
    Macarulla Mercade, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S189 - S189
  • [35] Origins, signatures, and clinical impacts of homologous recombination deficiency (HRD) in Asian breast cancers
    Ju, Young Seok
    Kim, Ryul
    Park, Yeon Hee
    Ju, Young Seok
    CANCER SCIENCE, 2025, 116 : 629 - 629
  • [36] Prevalence and clinical significance of pathogenic germline mutations in homologous recombination repair genes in Chinese lung cancer patients.
    Jiang, Yanxia
    Han, Liying
    Wang, Yan
    Wu, Nuoting
    Suo Peisu
    Huang, Tanxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients
    Barberis, Massimo
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (03) : 1 - 3
  • [38] Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS).
    Janjigian, Yelena Yuriy
    Jonsson, Philip
    Kemel, Yelena
    Joseph, Vijai
    Tuvy, Yaelle
    Shameer, Zarina
    Ravichandran, Vignesh
    Zhang, Liying
    Mandelker, Diana
    Ku, Geoffrey Yuyat
    Hechtman, Jaclyn Frances
    Kelsen, David Paul
    Ilson, David H.
    Offit, Kenneth
    Berger, Michael F.
    Schultz, Nikolaus
    Robson, Mark E.
    Solit, David B.
    Taylor, Barry S.
    Stadler, Zsofia Kinga
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes
    Zhao, Eric Y.
    Shen, Yaoqing
    Pleasance, Erin
    Kasaian, Katayoon
    Jones, Martin R.
    Ch'ng, Carolyn
    Reisle, Caralyn
    Eirew, Peter
    Mungall, Karen
    Thiessen, Nina
    Ma, Yussanne
    Fok, Alexandra
    Mungall, Andrew J.
    Zhao, Yongjun
    Moore, Richard
    Villa, Diego
    Shenkier, Tamara
    Lohrisch, Caroline
    Chia, Stephen
    Yip, Stephen
    Gelmon, Karen
    Lim, Howard
    Sun, Sophie
    Schrader, Kasmintan A.
    Young, Sean
    Karsan, Aly
    Roscoe, Robyn
    Laskin, Janessa
    Marra, Marco A.
    Jones, Steven J.
    CANCER RESEARCH, 2017, 77
  • [40] HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) SCORE IN CHINESE AGGRESSIVE PROSTATIC ADENOCARCINOMA WITH OR WITHOUT INTRADUCTAL CARCINOMA OF THE PROSTATE
    Zhu, Sha
    Zeng, Hao
    JOURNAL OF UROLOGY, 2022, 207 (05): : E630 - E631
12345